METTL3-dependent N6-methyladenosine modification is involved in berberine-mediated neuroprotection in ischemic stroke by enhancing the stability of NEAT1 in astrocytes
Aging · 2024-01-04
DOI: 10.18632/aging.205369 ↗At a glance
Journal article in Aging, published online on 2024-01-04. Written by Junya Hu and 9 co-authors. Institution: Department of Pharmacy, Nanjing First Hospital, China Pharmaceutical University, Nanjing 210006, China. Major MEDLINE topics: Ischemic Stroke, Berberine, MicroRNAs, Reperfusion Injury. Cited 7 times so far (Crossref); 55 references. The full text is freely available in PubMed Central.
Topics: Schlaganfall
Abstract (original language)
Ischemic stroke (IS) is one of the principal causes of disability and death worldwide. Berberine (BBR), derived from the traditional Chinese herbal medicine Huang Lian, has been reported to inhibit the progression of stroke, but the specific mechanism whereby BBR modulates the progression of ischemic stroke remains unclear. N6-methyladenosine (m6A) modification is the most typical epigenetic modification of mRNA post-transcriptional modifications, among which METTL3 is the most common methylation transferase. During the study, the middle cerebral artery occlusion/reperfusion (MCAO/R) was established in mice, and the mice primary astrocytes and neurons induced by oxygen-glucose deprivation/reoxygenation (OGD/R) was simulated in vitro. Level of LncNEAT1, miR-377-3p was detected via RT-qPCR. The levels of Nampt and METTL3 were measured by Western blot. CCK8 and LDH assay was performed to detect cell viability. Here, we found that berberine alleviates MCAO/R-induced ischemic injury and up-regulates the expression of Nampt in astrocytes, miR-377-3p inhibits the expression of Nampt in astrocytes after OGD/R, thus promoting neuronal injury. NEAT1 binds to miR-377-3p in OGD/R astrocytes and plays a neuronal protective role as a ceRNA. METTL3 can enhance NEAT1 stability in OGD/R astrocytes by modulating m6A modification of NEAT1. Taken together, our results demonstrate that berberine exerts neuroprotective effects via the m6A methyltransferase METTL3, which regulates the NEAT1/miR-377-3p/Nampt axis in mouse astrocytes to ameliorate cerebral ischemia/reperfusion (I/R) injury.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, Nanjing First Hospital, China Pharmaceutical University, Nanjing 210006, China.
- Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
- Department of Second Clinical Medical School, Nanjing Medical University, Nanjing 210000, China.
- Department of Neurology, Nanjing First Hospital, Nanjing 210006, China.
- Key Lab of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
Cite
APA
Hu, J., Duan, H., Zou, J., Ding, W., Wei, Z., Peng, Q., Li, Z., Duan, R., Sun, J., & Zhu, J. (2024). METTL3-dependent N6-methyladenosine modification is involved in berberine-mediated neuroprotection in ischemic stroke by enhancing the stability of NEAT1 in astrocytes. Aging. https://doi.org/10.18632/aging.205369
Vancouver
Hu J, Duan H, Zou J, Ding W, Wei Z, Peng Q, et al. METTL3-dependent N6-methyladenosine modification is involved in berberine-mediated neuroprotection in ischemic stroke by enhancing the stability of NEAT1 in astrocytes. Aging. 2024. doi:10.18632/aging.205369
BibTeX
@article{Hu2024,
author = {Hu, Junya and Duan, Huijie and Zou, Junqing and Ding, Wangli and Wei, Ziqiao and Peng, Qiang and Li, Zhongyuan and Duan, Rui and Sun, Jianguo and Zhu, Junrong},
title = {METTL3-dependent N6-methyladenosine modification is involved in berberine-mediated neuroprotection in ischemic stroke by enhancing the stability of NEAT1 in astrocytes},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205369}
}
EUVIMED